Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infectionArticle Published on 2020-07-012023-06-12 Journal: Lung cancer (Amsterdam, Netherlands) [Category] B형 간염, [키워드] HBV HCV Immunotherapy lung cancer PD-1 PD-L1 Viral hepatitis [DOI] 10.1016/j.lungcan.2020.02.013
The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidenceReview Published on 2020-06-012023-06-13 Journal: Cancer treatment reviews [Category] B형 간염, [키워드] Cancer Checkpoint inhibitor Chronic viral infection CTLA-4 hepatitis B hepatitis C HIV Immunotherapy PD-1 PD-L1 Reactivation [DOI] 10.1016/j.ctrv.2020.102011 [Article Type] Review
Clinicopathological evidence of hepatitis B virus infection in the development of gastric adenocarcinomaMeta-Analysis Published on 2020-01-012023-06-13 Journal: Journal of medical virology [Category] B형 간염, [키워드] Gastric cancer Hepatitis B virus PD-L1 [DOI] 10.1002/jmv.25584 [Article Type] Meta-Analysis
Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasionArticle Published on 2020-01-012023-06-13 Journal: American journal of physiology. Gastrointestinal and liver physiology [Category] B형 간염, [키워드] HBV immune evasion PD-L1 PTEN β-catenin [DOI] 10.1152/ajpgi.00197.2019
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibitionResearch Article Published on 2019-11-212023-06-03 Journal: Journal for immunotherapy of cancer [Category] B형 간염, Fulltext, [키워드] Cancer Checkpoint Hepatitis B virus Immunotherapy PD-1 PD-L1 Reactivation Safety [DOI] 10.1186/s40425-019-0808-5 PMC 바로가기 [Article Type] Research Article
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatmentReview Published on 2019-03-302023-08-30 Journal: Molecular Cancer [Category] E형 간염, [키워드] anti-angiogenesis CTLA-4 Immune checkpoint inhibitor PD-1 PD-L1 TKI Tumor immune microenvironment VEGF [DOI] 10.1186/s12943-019-0974-6 PMC 바로가기 [Article Type] Review
PD-L1 Expression Is Associated With VEGFA and LADC Patients’ SurvivalOriginal Research Published on 2019-03-262023-08-30 Journal: Frontiers in Oncology [Category] E형 간염, [키워드] lung adenocarcinoma overall survival PD-L1 progression-free survival VEGFA [DOI] 10.3389/fonc.2019.00189 PMC 바로가기 [Article Type] Original Research
Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinomaArticle Published on 2019-02-012023-06-18 Journal: Journal of cancer research and clinical oncology [Category] B형 간염, [키워드] HBV-related hepatocellular carcinoma Hepatitis B virus PD-L1 Prognosis Soluble PD-L1. [DOI] 10.1007/s00432-018-2758-6
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in CancerArticle Published on 2018-12-212023-08-30 Journal: Frontiers in Immunology [Category] E형 간염, [키워드] Angiogenesis Cancer Checkpoint blockade CTLA-4 endothelial activation PD-1 PD-L1 VEGF [DOI] 10.3389/fimmu.2018.03081 PMC 바로가기
Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infectionArticle Published on 2018-11-012023-06-19 Journal: Gut [Category] B형 간염, Fulltext, [키워드] HBV HLA-E Monocytes PD-L1 regulatory NK cells. [DOI] 10.1136/gutjnl-2017-314098 PMC 바로가기